Lucigen awarded $1.46 million R&D grant
Lucigen, a Middleton biotech firm, said Monday it has been awarded a $1.46 million grant from the National Institutes of Health to fund additional research and development, the Milwaukee Journal Sentinel reports. The Phase II Small Business Innovation Research grant will be used over the next three years to develop research tools with the potential to improve human health, the company said. (JOURNAL SENTINEL, 1/18)
To access this content, you must purchase a Premium membership, or log in if you are a member.
